XML 34 R24.htm IDEA: XBRL DOCUMENT
v3.26.1

Segment information (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Segment Reporting [Abstract] |
Schedule of Segment Financial Information | The following table summarizes the reportable segment's financial information (in thousands):
| Three Months Ended March 31, |
| 2026 |  | 2025 |
Revenue | $ | 106,677 |  |  | $ | 93,881 |  |
Less: |  |  |  |
Cost of revenue from sale of therapies | (434) |  |  | (831) |  |
External research and development (R&D) expenses: |  |  |  |
PRAME programs | (21,214) |  |  | (17,305) |  |
Tebentafusp programs | (8,239) |  |  | (7,990) |  |
Infectious disease programs | (846) |  |  | (1,405) |  |
All other external clinical and preclinical costs | (8,493) |  |  | (11,231) |  |
Total external R&D expenses | (38,792) |  |  | (37,931) |  |
R&D salaries and other employee-related costs | (14,140) |  |  | (11,043) |  |
Selling, general and administrative (SG&A) salaries and other employee-related costs | (13,090) |  |  | (12,218) |  |
Other SG&A expenses | (21,065) |  |  | (20,672) |  |
Other segment (expense) income, net (a) | (6,185) |  |  | (6,163) |  |
Segment and consolidated net income | $ | 12,971 |  |  | $ | 5,023 |  |
(a) Other segment expenses, net includes other internal R&D expenses, share-based compensation expense, R&D tax credits, interest income, interest expense, foreign currency gains, other income, net and income tax expense.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration